Healthcare

New drug pricing reform adviser named at HHS

Modern Healthcare: HHS announced Thursday that John O'Brien will succeed the late Dan Best in heading the agency's prescription drug pricing reform efforts.

O'Brien, a former health insurance executive, will serve as senior adviser for drug pricing reform to HHS Secretary Alex Azar. He previously served as Azar's adviser for health reform and drug pricing, as well as deputy assistant secretary for health policy within the Office of the Assistant Secretary for Planning and Evaluation.

Also in Healthcare Policy & IT

About

i360Gov is an intelligent network of websites and e-newsletters that provides
government business, policy and technology leaders with a single destination for the most
important news and analysis regarding their agency strategies and initiatives.

Contact Us

Telephone: 202.760.2280
Toll Free: 855.i360.Gov
Fax: 202.697.5045

Newsletters

The most significant government policy, business, and technology news and analysis delivered to your inbox.